mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.0087 |
0.9 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |